GlobeNewswire Inc.··Michael FrenchLexicon Pursues Rare Heart Disease Treatment as HCM Market Expands
Lexicon Pharmaceuticals advances sotagliflozin trials for hypertrophic cardiomyopathy, a genetic heart condition affecting thousands. Clinical results could reshape treatment landscape for rare disease.
LXRXclinical trialheart failure